Prime Medicine stock jumps 8% after FDA clears PM647 trial
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
AI borrowing pushes long-term bond yields to 15-year highs
Long-term bond yields have risen to their highest levels in 15 years or more across most major advanced economies, with heavy borrowing by artificial intelligence companies emerging as one of the…
Rupiah set for biggest weekly fall since May as higher US yields, stronger dollar bite
SINGAPORE: Indonesia's rupiah was set for its biggest weekly fall since late May on Friday, pressured by rising US Treasury yields, a stronger dollar and expectations that US interest rates will…
Meta’s Muse AI Downloads Are Soaring. Is It Time to Buy This Bargain AI Stock?
Muse even surpassed ChatGPT as a top free app.
Nikkei Climbs 850 Points as Chip Shares and Dividend Buying Lift Tokyo
Tokyo stocks rose strongly on September 25, with the Nikkei 225 closing at 66,364, up 850 points, as buying in semiconductor and artificial intelligence-related shares combined with demand for…
